Head Operations (Biopharmaceutical Green Field Project ) @ NUVVAGEN BIOSCIENCE (P) LTD (April 2024 - March 2026)
Head QMS and Regulatory (Interim Plant Head and Business Officer) @ (August 2021 - March 2024)
Director - Operations @ (January 2020 - August 2021)
Manager Quality Assurance and Regulatory Affairs @ (October 2015 - January 2020)
Manager Quality Management Systems @ (July 2011 - October 2015)
Sr. Executive @ (January 2005 - January 2011)
Avinash Patil Education
Birla Institute of Technology and Science, Pilani
Master of Science (M.S.) (Quality Management)
Shivaji University
Master of Science (M.Sc.) (Microbiology)
Avinash Patil Skills
Cleaning Validation
Sop
GMP
Validation
Regulatory Affairs
ANDA
Technology Transfer
GLP
CAPA
Pharmaceutical Industry
FDA
Regulatory Requirements
Change Control
21 CFR Part 11
Pharmaceutics
Regulatory Submissions
Quality System
GxP
Risk Assessment
Quality Auditing
Data Integrity
Deviation Management
Quality Assurance
Computer System Validation
Biotechnology
Biopharmaceuticals
Software Documentation
Microbiology
Quality Control
Dissolution
Aseptic Processing
Deviations
HPLC
eCTD
Standard Operating Procedure (SOP)
Good Laboratory Practice Glp
Standard Operating Procedure Sop
Public Relations
Abbreviated New Drug Application Anda
Customer Service
Standard Operating Procedure
Good Laboratory Practice
Abbreviated New Drug Application
Avinash Patil Summary
Avinash Patil, based in Mumbai, MH, IN, is currently a Senior Consultant at Freelance | Self-Employed pharmaceutical. Avinash Patil brings experience from previous roles at NUVVAGEN BIOSCIENCE (P) LTD, Alfa Pharmaceuticals Limited, Pharmaceutical Manufacturing and 3M India Healthcare. Avinash Patil holds a Master of Science (M.S.) in Quality Management @ Birla Institute of Technology and Science, Pilani. With a robust skill set that includes Cleaning Validation, Sop, GMP, Validation, Regulatory Affairs and more. Avinash Patil has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Avinash Patil?
Find contact details for 700 million professionals.